These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17227834)

  • 21. Antithrombotic and hemorrhagic effects of DX-9065a, a direct and selective factor Xa inhibitor: comparison with a direct thrombin inhibitor and antithrombin III-dependent anticoagulants.
    Morishima Y; Tanabe K; Terada Y; Hara T; Kunitada S
    Thromb Haemost; 1997 Nov; 78(5):1366-71. PubMed ID: 9408021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of the joint administration of heparin and chitosan sulfate ether on hemostatic function].
    Drozd NN; Makarov VA; Bashkov GV; Gal'braĭkh LS; Vikhoreva GA; Gorbacheva IN
    Eksp Klin Farmakol; 1996; 59(1):30-3. PubMed ID: 8704629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis.
    Biemond BJ; Friederich PW; Levi M; Vlasuk GP; Büller HR; ten Cate JW
    Circulation; 1996 Jan; 93(1):153-60. PubMed ID: 8616922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
    Kitazato K; Kitazato KT; Sasaki E; Minamiguchi K; Nagase H
    Thromb Res; 2003; 112(1-2):83-91. PubMed ID: 15013278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The protein C activator AB002 rapidly interrupts thrombus development in baboons.
    Tucker EI; Verbout NG; Markway BD; Wallisch M; Lorentz CU; Hinds MT; Shatzel JJ; Pelc LA; Wood DC; McCarty OJT; Di Cera E; Gruber A
    Blood; 2020 Feb; 135(9):689-699. PubMed ID: 31977000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The thrombin mutant W215A/E217A shows safe and potent anticoagulant and antithrombotic effects in vivo.
    Gruber A; Cantwell AM; Di Cera E; Hanson SR
    J Biol Chem; 2002 Aug; 277(31):27581-4. PubMed ID: 12070133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model.
    Gruber A; Griffin JH; Harker LA; Hanson SR
    Blood; 1989 Feb; 73(3):639-42. PubMed ID: 2917194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated protein C inhibits thrombus formation in a system with flowing blood.
    Lozano M; Escolar G; Schwarz HP; Hernández R; Bozzo J; Ordinas A
    Br J Haematol; 1996 Oct; 95(1):179-83. PubMed ID: 8857957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of activated human protein C on experimental venous thrombosis induced by stasis with operative invasion in mice.
    Aoki Y; Fukumoto Y; Inoue K; Katsuura Y; Komoriya K; Miyamoto S
    Arzneimittelforschung; 2000 Aug; 50(8):695-9. PubMed ID: 10994152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of antithrombotic and hemorrhagic effects of edoxaban, a novel factor Xa inhibitor, with unfractionated heparin, dalteparin, lepirudin and warfarin in rats.
    Morishima Y; Honda Y; Kamisato C; Shibano T
    Thromb Res; 2013 Aug; 132(2):234-9. PubMed ID: 23768448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prourokinase mutant that induces highly effective clot lysis without interfering with hemostasis.
    Liu JN; Liu JX; Liu Bf BF; Sun Z; Zuo JL; Zhang Px PX; Zhang J; Chen Yh YH; Gurewich V
    Circ Res; 2002 Apr; 90(7):757-63. PubMed ID: 11964367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermatan sulfate inhibition of fibrin-rich thrombus formation in nonhuman primates.
    Cadroy Y; Hanson SR; Harker LA
    Arterioscler Thromb; 1993 Aug; 13(8):1213-7. PubMed ID: 8343496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons.
    Runge MS; Harker LA; Bode C; Ruef J; Kelly AB; Marzec UM; Allen E; Caban R; Shaw SY; Haber E; Hanson SR
    Circulation; 1996 Sep; 94(6):1412-22. PubMed ID: 8823001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeated Oral or Subcutaneous LMWH Has similar Antithrombotic Activity in a Rat Venous Thrombosis Model: Antithrombotic Activity Correlates With Heparin on Endothelium When Orally Administered.
    Hiebert LM
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):264-272. PubMed ID: 27653610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihemostatic and antithrombotic effects of monoclonal antibodies against von Willebrand factor in nonhuman primates.
    Krupski WC; Bass A; Cadroy Y; Kelly AB; Harker LA; Hanson SR
    Surgery; 1992 Aug; 112(2):433-9; discussion 439-40. PubMed ID: 1641780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of microarterial thrombosis by activated protein C in a rabbit model.
    Arnljots B; Bergqvist D; Dahlbäck B
    Thromb Haemost; 1994 Sep; 72(3):415-20. PubMed ID: 7855793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of hemorrhagic effect of heparin and human activated protein C with use of Thrombostat 4000.
    Katsuura Y; Tanabe H; Kiyoki M; Funatsu A
    Haemostasis; 1996; 26(4):203-9. PubMed ID: 8872131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombotic effects of activated protein C and protein S in a rabbit model of microarterial thrombosis.
    Arnljots B; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):937-41. PubMed ID: 7600126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo.
    Tsiang M; Paborsky LR; Li WX; Jain AK; Mao CT; Dunn KE; Lee DW; Matsumura SY; Matteucci MD; Coutré SE; Leung LL; Gibbs CS
    Biochemistry; 1996 Dec; 35(51):16449-57. PubMed ID: 8987977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.